Cyclacel Pharmaceuticals, Inc. 4
4 · Cyclacel Pharmaceuticals, Inc. · Filed Jun 26, 2007
Insider Transaction Report
Form 4
Reyes Gregory
Senior VP, Research
Transactions
- Award
Options
2007-06-22+55,000→ 55,000 totalExercise: $6.86Exp: 2017-06-22→ Common Stock (55,000 underlying)
Footnotes (2)
- [F1]These options are exercisable over a four-year period with one-quarter (1/4) of the options granted vesting on June 22, 2008, the first anniversary of the grant date, and 1/48 of the total of the options granted vesting monthly thereafter.
- [F2]These options were granted to Mr. Reyes in connection with his commencement as an officer of the Issuer.